{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:12:33Z","timestamp":1758960753963,"version":"3.37.3"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT BACKGROUND: Helicobacter pylori (H. pylori) has been introduced by since 1983 by Marshal and Warren to play the main role in the pathophysiology of gastritis and gastric ulcers. Almost half of the world population1 is infected by H. pylori. Current therapeutic regimen against H. pylori includes the use of a proton pump inhibitor plus two or more antibiotics. However, the efficacy of this regimen is decreasing mainly due to antibiotic resistance and side effects of medications. This fact has resulted in public interest in other therapeutic options and the role of probiotics merits special attention in this regard. OBJECTIVE: This study aims to evaluate the efficacy of honey-derived Lactobacillus rhamnosus on H. pylori-induced gastric inflammation and gastro-intestinal infection in C57BL\/6 Mice. METHODS: The 24 C57BL\/6 Mice were randomly divided into three groups of eight mice each. All the mice were fed with 1cc suspension containing 5*1010 CFU\/ mL of ATCC43504 strains of H. pylori for 3 consecutive days, twice daily via polyethylene gavage tubes. At the end of 4th week, infection with H. pylori was confirmed with stool Ag (ELISA) and following sacrifice of one mouse from each group, histopathologic study confirmed gastritis. The groups were subjected to different therapies as stated, 1: without Bismuth (Bi), Omeprazole (Om) and L. rhamnosus prescription, 2: Bi, Om and Clarithromycin (Cl) and 3: Bi, Om plus 1cc of suspension of 109 CFU\/mL of L. rhamnosus. After 2 weeks, the stool was analyzed for Ag and the mice were sacrificed for evaluation of histopathologic changes. RESULTS: Treatment with L. rhamnosus group provided Zero titer of stool Ag and was associated with improved gastric inflammation in all subjects, similar to the clarithromycin group. CONCLUSION: Honey-derived L. rhamnosus probiotics provides similar results as clarithromycin in terms of improvement of H. pylori infection and gastritis in C57BL\/6 Mice model, without its cons of antibiotic resistance.<\/jats:p>","DOI":"10.1590\/s0004-2803.201800000-70","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T18:25:57Z","timestamp":1544898357000},"page":"279-282","source":"Crossref","is-referenced-by-count":11,"title":["HONEY-DERIVED LACTOBACILLUS RHAMNOSUS ALLEVIATES HELICOBACTER PYLORI-INDUCED GASTRO-INTESTINAL INFECTION AND GASTRIC INFLAMMATION IN C57BL\/6 MICE: AN IMMUNO-HISTOLOGIC STUDY"],"prefix":"10.1590","volume":"55","author":[{"given":"Behnoush","family":"ASGARI","sequence":"first","affiliation":[{"name":"Alborz University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"KERMANIAN","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"DERAKHSHAN","sequence":"additional","affiliation":[{"name":"Shiraz University of edical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"ASNA-ASHARI","sequence":"additional","affiliation":[{"name":"Laboratory Science Medicine, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra Rouhani Nojede","family":"SADAT","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8423-0652","authenticated-orcid":false,"given":"Somayeh","family":"YASLIANIFARD","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.micpath.2016.09.016","article-title":"Clinical relevance of Helicobacter pylori virulence factors in Iranian patients with gastrointestinal diseases","volume":"100","author":"Bagheri N","year":"2016","journal-title":"Microb Pathog"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12178","article-title":"clinical management of Helicobacter pylori infection in China","volume":"20","author":"Xie C","year":"2015","journal-title":"Helicobacter"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3748\/wjg.v12.i19.2991","article-title":"Helicobacter pylori infection causes gastric cancer A? review of the epidemiological, meta-analytic, and experimental evidence","volume":"12","author":"Eslick GD","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura S","year":"2012","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/ajg.2009.314","article-title":"Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis","volume":"104","author":"Zullo A","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire P","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1572-0241.2002.05663.x","article-title":"H. pylori and gastric cancer: the Asian enigma","volume":"97","author":"Miwa H","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.1999.01360.x","article-title":"Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis","volume":"94","author":"Eslick GD","year":"1999","journal-title":"The American journal of gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/hel.12085","article-title":"Ten\u2010Day Quadruple Therapy Comprising Proton\u2010Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for Helicobacter pylori Infection after Failure of Sequential Therapy","volume":"19","author":"Hsu PI","year":"2014","journal-title":"Helicobacter"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1523-5378.1996.tb00003.x","article-title":"Treatment of Helicobacter pylori infection: a review of the world literature","volume":"1","author":"Der Hulst RW","year":"1996","journal-title":"Helicobacter"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham DY","year":"2010","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1365-2036.2000.00885.x","article-title":"A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates","volume":"14","author":"Canducci F","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejbt.2016.11.008","article-title":"Characterization of Lactobacillus fermentum UCO-979C, a probiotic strain with a potent anti-Helicobacter pylori activity","volume":"25","author":"Garc\u00eda A","year":"2017","journal-title":"Electron J Biotechnol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta\u2010analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong J","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.clinre.2017.04.004","article-title":"Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis","volume":"41","author":"Wang F","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref16","first-page":"63","article-title":"Probiotics as Anti-Helicobacter pylori Agent: State of the Art","volume":"15","author":"Talebi Bezmin Abadi A","year":"2017","journal-title":"Antiinfect Agents"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/jee\/97.3.752","article-title":"Bacterial probiotics induce an immune response in the honey bee (Hymenoptera: Apidae)","volume":"97","author":"Evans JD","year":"2004","journal-title":"J Econ Entomol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/426309","article-title":"H. pylori virulence factors: influence on immune system and pathology","volume":"2014","author":"Kalali B","year":"2014","journal-title":"Mediators Inflamm"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/hel.12282","article-title":"The Presence of Phage Orthologous Genes in Helicobacter pylori Correlates with the Presence of the Virulence Factors CagA and VacA","volume":"21","author":"Kyrillos A","year":"2016","journal-title":"Helicobacter"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5662\/wjm.v5.i3.164","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review","volume":"5","author":"Ghotaslou R","year":"2015","journal-title":"World J Methodol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0924-8579(03)00153-5","article-title":"The role of probiotics in the treatment and prevention of Helicobacter pylori infection","volume":"22","author":"Hamilton-Miller J","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore MP","year":"2016","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/MJT.0000000000000389","article-title":"Role of Bismuth in the Eradication of Helicobacter pylori","volume":"24","author":"Alkim H","year":"2017","journal-title":"Am J Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/014107689909200832","article-title":"Manuka honey against Helicobacter pylori","volume":"92","author":"McGovern DP","year":"1999","journal-title":"J R Soc Med"},{"key":"ref25","first-page":"139","article-title":"Inhibitory effect of natural honey on Helicobacter pylori","volume":"12","author":"Ali A","year":"1991","journal-title":"Trop Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/014107689408700106","article-title":"Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey","volume":"87","author":"Al Somal N","year":"1994","journal-title":"J R Soc Med"},{"key":"ref27","first-page":"67","article-title":"Evaluation of anti-Helicobacter pylori activity and urease inhibition by some Turkish authentic honeys","volume":"7","author":"Kolayl\u0131 S","year":"2017","journal-title":"JFSE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3748\/wjg.v20.i6.1450","article-title":"Exploring alternative treatments for Helicobacter pylori infection","volume":"20","author":"Ayala G","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.4103\/0973-1296.210166","article-title":"Isolation of abscisic acid from Korean acacia honey with anti-Helicobacter pylori activity","volume":"13","author":"Kim S","year":"2017","journal-title":"Pharmacogn Mag"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v55n3\/1678-4219-ag-55-03-279.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:32:28Z","timestamp":1662640348000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032018002300279&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["S0004-28032018002300279"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201800000-70","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"type":"electronic","value":"1678-4219"},{"type":"print","value":"0004-2803"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}